D End
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
Papers in ⓘ
-
- Endoplasmic Reticulum Stress and Disease 2
- Co-authors
- Gordon Guroff (4 shared papers)Karen Huff (1 shared paper)Christine Toulas (2 shared papers)Caroline Delmas (2 shared papers)Gilles Favre (2 shared papers)Elizabeth Cohen–Jonathan (2 shared papers)Seiichi Hashimoto (2 shared papers)N. Tolson (2 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)The Journal of Cell Biology (1 paper)European Journal of Organic Chemistry (1 paper)Journal of Clinical Oncology (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesBelgiumCameroon
In The Last Decade
D End
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 83
- Oncology 401
- Cancer Research 173
- Molecular Biology 744
- Hematology 108
- Genetics 100
Countries citing papers authored by D End
This map shows the geographic impact of D End's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D End with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D End more than expected).
Fields of papers citing papers by D End
This network shows the impact of papers produced by D End. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D End. The network helps show where D End may publish in the future.
Co-authors
The 25 scholars most cited alongside D End, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 233 | |
| 2 | 2000 | 218 | |
| 3 | 2007 | 209 | |
| 4 | 2004 | 110 | |
| 5 | Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancer. | 2001 | 79 |
| 6 | 2002 | 77 | |
| 7 | The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft. | 2003 | 60 |
| 8 | 1983 | 50 | |
| 9 | 1992 | 41 | |
| 10 | 2005 | 22 | |
| 11 | 1982 | 22 | |
| 12 | 2008 | 20 | |
| 13 | 2005 | 18 | |
| 14 | 1977 | 18 | |
| 15 | 1980 | 16 | |
| 16 | 1981 | 16 | |
| 17 | 1985 | 9 | |
| 18 | Characterization of a high affinity interleukin-1 (IL-1) specific binding site in a human synovial sarcoma (Hs431) cell line. | 1990 | 3 |
About D End
D End is a scholar working on Behavioral Neuroscience, Cell Biology, Oncology, Cellular and Molecular Neuroscience and Molecular Biology, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Cancer Treatment and Pharmacology (2 papers), Nerve injury and regeneration (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Retinoids in leukemia and cellular processes (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Platelet Disorders and Treatments (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Oncology (401 citations), Cancer Research (173 citations), Molecular Biology (744 citations), Hematology (108 citations) and Genetics (100 citations). D End has collaborated with scholars based in United States, Belgium and Cameroon. Frequent co-authors include Gordon Guroff, Karen Huff, Christine Toulas, Caroline Delmas, Gilles Favre, Elizabeth Cohen–Jonathan, Seiichi Hashimoto, N. Tolson, Marc Venet and Patrick Angibaud. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Cell Biology, European Journal of Organic Chemistry, Journal of Clinical Oncology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.